Brown recluse spider (Loxosceles reclusa) venom phospholipase D (PLD) generates lysophosphatidic acid (LPA)

被引:110
作者
Lee, S [1 ]
Lynch, KR [1 ]
机构
[1] Univ Virginia, Sch Sci, Dept Pharmacol, Charlottesville, VA 22908 USA
关键词
brown recluse spider; Loxosceles envenomation; lysophosphatidic acid (LPA); lysophosphatidylcholine (LPQ; phospholipase D (PLD); sphingomyelinase D (SMaseD);
D O I
10.1042/BJ20050043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Envenomation by the brown recluse spider (Loxosceles reclusa) may cause local dermonecrosis and, rarely, coagulopathies, kidney failure and death. A venom phospholipase, SMaseD (sphingomyelinase D), is responsible for the pathological manifestations of envenomation. Recently, the recombinant SMaseD from Loxosceles laeta was demonstrated to hydrolyse LPC (lysophosphatidylcholine) to produce LPA (lysophosphatidic acid) and choline. Therefore activation of LPA signalling pathways may be involved in some manifestations of Loxosceles envenomation. To begin investigating this idea, we cloned a full-length cDNA encoding L. reclusa SMaseD. The 305 amino acid sequence of the L. reclusa enzyme is 87, 85 and 60% identical with those of L. arizonica, L. intermedia and L. laeta respectively. The recombinant enzyme expressed in bacteria had broad substrate specificity. The lysophospholipids LPC, LPI (18:1-1-oleyol lysophosphatidylinositol), LPS, LPG (18:1-1-oleoyl-lysophosphatidylglycerol), LBPA (18:1-1-oleoyl-lysobisphosphatidic acid) (all with various acyl chains), lyso-platelet-activating factor (C-16:0), cyclic phosphatidic acid and sphingomyelin were hydrolysed, whereas sphingosylphosphorylcholine, PC (phosphatidylcholine; C-22:6, C-20:4 and C-6:0), oxidized PCs and PAF (platelet-activating factor; C16:0) were not hydrolysed. The PAF analogue, edelfosine, inhibited enzyme activity. Recombinant enzyme plus LPC (C-18:1) induced the migration of A2058 melanoma cells, and this activity was blocked by the LPA receptor antagonist, VPC32183. The recombinant spider enzyme was haemolytic, but this activity was absent from catalytically inactive H37N (His(37) -> Asn) and H73N mutants. Our results demonstrate that Loxosceles phospholipase D hydrolyses a wider range of lysophospholipids than previously supposed, and thus the term 'SMaseD' is too limited in describing this enzyme.
引用
收藏
页码:317 / 323
页数:7
相关论文
共 26 条
[1]   Lysophospholipid G protein-coupled receptors [J].
Anliker, B ;
Chun, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (20) :20555-20558
[2]   Serum lysophosphatidic acid is produced through diverse phospholipase pathways [J].
Aoki, J ;
Taira, A ;
Takanezawa, Y ;
Kishi, Y ;
Hama, K ;
Kishimoto, T ;
Mizuno, K ;
Saku, K ;
Taguchi, R ;
Arai, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) :48737-48744
[3]   The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro [J].
Cardile, V ;
Mascarucci, P ;
DeSimoni, MG ;
Jiang, XH ;
Bindoni, M .
CYTOKINE, 1996, 8 (09) :698-701
[4]  
Clair T, 2003, CANCER RES, V63, P5446
[5]   Ceramide-1-phosphate:: a novel regulator of cell activation [J].
Gómez-Muñoz, A .
FEBS LETTERS, 2004, 562 (1-3) :5-10
[6]   Raft ceramide in molecular medicine [J].
Gulbins, E ;
Kolesnick, R .
ONCOGENE, 2003, 22 (45) :7070-7077
[7]   Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1 [J].
Hama, K ;
Aoki, J ;
Fukaya, M ;
Kishi, Y ;
Sakai, T ;
Suzuki, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (17) :17634-17639
[8]   Molecular cloning, expression and immunological properties of LiD1, a protein from the dermonecrotic family of, Loxosceles intermedia spider venom [J].
Kalapothakis, E ;
Araujo, SC ;
de Castro, CS ;
Mendes, TM ;
Gomez, MV ;
Mangili, OC ;
Gubert, IC ;
Chávez-Olórtegui, C .
TOXICON, 2002, 40 (12) :1691-1699
[9]   A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method [J].
Kishimoto, T ;
Matsuoka, T ;
Imamura, S ;
Mizuno, K .
CLINICA CHIMICA ACTA, 2003, 333 (01) :59-67
[10]  
Koh E, 2003, CANCER RES, V63, P2042